Suppr超能文献

雄激素受体-长链非编码 RNA SAT1-AKT-p15 轴介导雄激素诱导的前列腺癌细胞衰老。

The androgen receptor-lncRNASAT1-AKT-p15 axis mediates androgen-induced cellular senescence in prostate cancer cells.

机构信息

Institute of Human Genetics, Jena University Hospital, Jena, Germany.

Leibniz Institute on Aging, Jena, Germany.

出版信息

Oncogene. 2022 Feb;41(7):943-959. doi: 10.1038/s41388-021-02060-5. Epub 2021 Oct 19.

Abstract

The bipolar androgen therapy (BAT) to treat prostate cancer (PCa) includes cycles of supraphysiological androgen levels (SAL) under androgen-deprivation therapy (ADT). We showed previously that SAL induces cellular senescence in androgen-sensitive PCa cells and in ex vivo-treated patient PCa tumor samples. Here, we analyzed the underlying molecular pathway and reveal that SAL induces cellular senescence in both, castration-sensitive (CSPC) LNCaP and castration-resistant PCa (CRPC) C4-2 cells through the cell cycle inhibitor p15 and increased phosphorylation of AKT. Treatment with the AKT inhibitor (AKTi) potently inhibited SAL-induced expression of p15 and cellular senescence in both cell lines. Proximity-ligation assays (PLA) combined with high-resolution laser-scanning microscopy indicate that SAL promotes interaction of endogenous androgen receptor (AR) with AKT in the cytoplasm as well as in the nucleus detectable after three days. Transcriptome sequencing (RNA-seq) comparing the SAL-induced transcriptomes of LNCaP with C4-2 cells as well as with AKTi-treated cell transcriptomes revealed landscapes for cell senescence. Interestingly, one of the identified genes is the lncRNASAT1. SAL treatment of native patient tumor samples ex vivo upregulates lncRNASAT1. In PCa tumor tissues, lncRNASAT1 is downregulated compared with nontumor tissues of the same patients. Knockdown indicates that the lncRNASAT1 is crucial for SAL-induced cancer-cell senescence as an upstream factor for pAKT and for p15. Further, knockdown of lncRNASAT1 enhances cell proliferation by SAL, suggesting that lncRNASAT1 serves as a tumor suppressor at SAL. Interestingly, immunoprecipitation of AR detected lncRNASAT1 as an AR-interacting partner that regulates AR target-gene expression. Similarly, RNA-ChIP experiments revealed the interaction of AR with lncRNASAT1 on chromatin. Thus, we identified a novel AR-lncRNASAT1-AKT-p15 signaling axis to mediate SAL-induced cellular senescence.

摘要

双相雄激素治疗 (BAT) 用于治疗前列腺癌 (PCa),包括雄激素剥夺治疗 (ADT) 下的超生理雄激素水平 (SAL) 循环。我们之前表明,SAL 诱导雄激素敏感型 PCa 细胞和体外处理的患者 PCa 肿瘤样本中的细胞衰老。在这里,我们分析了潜在的分子途径,并揭示 SAL 通过细胞周期抑制剂 p15 和 AKT 的磷酸化,诱导去势敏感型 (CSPC) LNCaP 和去势抵抗型 PCa (CRPC) C4-2 细胞的衰老。用 AKT 抑制剂 (AKTi) 处理可有效抑制两种细胞系中 SAL 诱导的 p15 表达和细胞衰老。基于接近连接分析 (PLA) 结合高分辨率激光扫描显微镜检测表明,SAL 促进内源性雄激素受体 (AR) 在细胞质和细胞核中的相互作用,这在 3 天后可检测到。比较 LNCaP 和 C4-2 细胞的 SAL 诱导转录组以及 AKTi 处理细胞转录组的转录组测序 (RNA-seq) 揭示了细胞衰老的图谱。有趣的是,鉴定出的一个基因是 lncRNASAT1。SAL 处理体外原代患者肿瘤样本可上调 lncRNASAT1。在 PCa 肿瘤组织中,与同一患者的非肿瘤组织相比,lncRNASAT1 下调。敲低表明 lncRNASAT1 作为 pAKT 和 p15 的上游因子,对 SAL 诱导的癌细胞衰老至关重要。此外,lncRNASAT1 的敲低通过 SAL 增强细胞增殖,表明 lncRNASAT1 在 SAL 下作为肿瘤抑制因子发挥作用。有趣的是,AR 的免疫沉淀检测到 lncRNASAT1 是调节 AR 靶基因表达的 AR 相互作用伙伴。同样,RNA-ChIP 实验显示 AR 与染色质上的 lncRNASAT1 相互作用。因此,我们确定了一种新的 AR-lncRNASAT1-AKT-p15 信号轴,用于介导 SAL 诱导的细胞衰老。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57be/8837536/55e10deb26fd/41388_2021_2060_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验